Skip to main content

Table 1 Validation of the docking protocol employed in the study

From: A computational multi-targeting approach for drug repositioning for psoriasis treatment

Target

PDB Code

Grid Box Origin

Grid Box Radius

RMSD

X

Y

Z

X

Y

Z

A2AR

2YDO

−28.9352

9.0723

−23.3486

4.0

7.0

4.0

1.60

BTK

4OTF

−37.9926

26.1210

−9.4603

7.0

6.0

10.5

1.56

CS

5QC5

42.8295

−4.4045

42.1155

8.0

8.0

8.0

1.65

Il-17α

5HI4

78.6552

−44.1998

−45.5098

8.0

8.0

8.0

1.88

Il-23

3QWR

23.5974

−26.6082

−51.9151

8.0

8.0

8.0

1.72

JaK-3

5TTS

−0.2570

17.8777

−5.2946

7.7

8.0

7.0

1.53

P38-MAPK

3NEW

24.4628

16.3186

10.6828

5.0

5.5

4.9

0.94

PDE-4

5K1I

12.5596

3.8457

68.4582

6.0

6.0

6.3

1.48

PAD

4X8G

26.8987

45.0298

26.6235

8.0

8.0

8.0

1.64

Pim-1 Kinase

4A7C

−41.1394

−3.0677

2.5015

6.0

5.5

6.2

0.86

PKC

5F9E

26.2347

78.7212

29.1280

8.0

6.0

8.0

1.16

RAC-1

5VCU

2.3215

−21.9062

−6.8930

8.0

5.0

8.0

1.23

SPK

4XG6

0.4376

−3.1674

7.0491

6.0

7.0

6.0

1.86

S1PR

3V2W

7.4851

17.6949

−8.9697

8.0

8.0

8.0

1.66

TNF-α

2AZ5

−19.0000

74.2776

33.5624

6.0

6.3

6.8

1.47

  1. A2AR Adenosine A2 Receptor, BTK Bruton’s Tyrosine Kinase, CS Cathepsin S, IL-17A Interleukin-17A, IL-23 Interleukin-23, JaK-3 Janus Kinase 3, P38-MAPK Mitogen-activated Protein Kinase-p38, PDE-4 Phosphodiesterase-4, PAD Peptidylarginine Deiminase, Pim-1 kinase ProviralIntegration site for Moloney Murine Leukemia Virus-1 Kinase, PKC Protein Kinase C, RAC-1 Ras-related C3 Botulinum Toxin Substrate-1, S1PR Sphingosine 1-Phosphate Receptor, SPK Protein Kinase C, and TNF-α Tumor Necrosis Factor-alpha